Integer Holdings Co. (NYSE:ITGR) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP decreased its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 68.8% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,088 shares of the medical equipment provider's stock after selling 11,208 shares during the quarter. Bridgewater Associates LP's holdings in Integer were worth $661,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Blue Trust Inc. grew its position in shares of Integer by 460.4% during the second quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider's stock worth $658,000 after purchasing an additional 4,636 shares in the last quarter. Loomis Sayles & Co. L P lifted its stake in shares of Integer by 3.0% during the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider's stock worth $69,943,000 after acquiring an additional 15,446 shares during the last quarter. Earnest Partners LLC lifted its stake in shares of Integer by 3.2% during the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider's stock worth $139,911,000 after acquiring an additional 37,340 shares during the last quarter. Great Lakes Advisors LLC lifted its stake in shares of Integer by 56.7% during the 2nd quarter. Great Lakes Advisors LLC now owns 45,218 shares of the medical equipment provider's stock worth $5,236,000 after acquiring an additional 16,355 shares during the last quarter. Finally, SG Americas Securities LLC bought a new stake in Integer during the 3rd quarter valued at $651,000. Institutional investors own 99.29% of the company's stock.

Integer Price Performance

NYSE ITGR traded up $2.39 during trading hours on Tuesday, reaching $141.16. The company's stock had a trading volume of 304,771 shares, compared to its average volume of 307,022. The firm has a market capitalization of $4.73 billion, a price-to-earnings ratio of 42.82, a P/E/G ratio of 2.02 and a beta of 1.12. Integer Holdings Co. has a 1-year low of $86.42 and a 1-year high of $142.00. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The company's 50-day moving average is $131.59 and its two-hundred day moving average is $124.64.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The company had revenue of $431.42 million during the quarter, compared to analysts' expectations of $440.59 million. During the same quarter in the prior year, the firm posted $1.27 EPS. Integer's quarterly revenue was up 8.7% compared to the same quarter last year. On average, equities analysts predict that Integer Holdings Co. will post 5.33 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Citigroup lifted their target price on Integer from $124.00 to $130.00 and gave the company a "neutral" rating in a research report on Tuesday, October 1st. Bank of America lifted their price target on Integer from $135.00 to $145.00 and gave the company a "buy" rating in a report on Tuesday, October 1st. Benchmark lifted their price target on Integer from $130.00 to $140.00 and gave the company a "buy" rating in a report on Monday, October 21st. Piper Sandler restated an "overweight" rating and set a $140.00 target price (up from $125.00) on shares of Integer in a research note on Friday, October 25th. Finally, Truist Financial dropped their target price on Integer from $150.00 to $147.00 and set a "buy" rating on the stock in a research note on Friday, October 25th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $142.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.